<unk> , sold under the brand name Trajenta among others, is a medication used to treat diabetes mellitus type 2. It is generally less preferred than metformin and sulfonylureas as an initial treatment. It is used together with exercise and diet. It is not recommended in type 1 diabetes. It is taken by mouth. Common side effects include inflammation of the nose and throat. Serious side effects may include angioedema, pancreatitis, joint pain. Use in pregnancy and breastfeeding is not recommended.<unk>  is a dipeptidyl peptidase-4 inhibitor. It works by increasing the production of insulin and decreasing the production of glucagon by the pancreas.<unk>  was approved for medical use in the United States in 2011. In 2018, it was the 177th most commonly prescribed medication in the United States, with more than 3million prescriptions. As of August 2021,<unk>  is available as a generic medicine in the US.
Linagliptin
Liraglutide
Vildagliptin
Exenatide
Saxagliptin
Sitagliptin
Pioglitazone
Canagliflozin